Trial begins for Digirad's Cardius X-ACT
Article Thumbnail ImageSeptember 5, 2008 -- Nuclear medicine vendor Digirad of Poway, CA, has begun clinical trials for a new imaging module designed to correct image distortion in cardiac SPECT imaging.
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • Initial clinical trials for Cardius X-ACT will take place at the University of California, Los Angeles (UCLA) to improve imaging clarity and accuracy and reduce imaging time and radiation dose.

    Two other clinical studies are planned for the system, which is based on Digirad's Cardius 3 triple-head SPECT camera.

    Digirad hopes to market Cardius X-ACT sometime next year after receiving regulatory clearance.

    Related Reading

    Novel cardiac SPECT system improves attenuation correction, August 15, 2008

    Digirad posts loss in Q2, July 29, 2008

    Digirad signs deal with U. of Chicago, April 29, 2008

    Digirad Q1 results dip into red, April 24, 2008

    Digirad fined by NRC, April 8, 2008

    Copyright © 2008 AuntMinnie.com


    || About || Advertising || AuntMinnieCME.com || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 AuntMinnie.com. All Rights Reserved.